Lord Weir of Ballyholme Alert Sample


Alert Sample

View the Parallel Parliament page for Lord Weir of Ballyholme

Information between 3rd September 2026 - 13th September 2026

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Calendar
Friday 23rd October 2026
Lord Weir of Ballyholme (Democratic Unionist Party - Life peer)

Legislation - Main Chamber
Subject: British Sovereignty Protection (Chagos Islands) Bill – second reading
British Sovereignty Protection (Chagos Islands) Bill [HL] 2026-27
View calendar - Add to calendar


Division Votes
3 Sep 2026 - Nature Restoration Levy Regulations 2026 - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and in line with the House
One of 1 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 41 Noes - 29
9 Sep 2026 - Financial Services and Markets Bill [HL] - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and in line with the House
One of 1 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 194 Noes - 138
9 Sep 2026 - Financial Services and Markets Bill [HL] - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and in line with the House
One of 3 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 248 Noes - 163
9 Sep 2026 - Financial Services and Markets Bill [HL] - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and in line with the House
One of 1 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 188 Noes - 125
7 Sep 2026 - Financial Services and Markets Bill [HL] - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and against the House
One of 3 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 76 Noes - 164
7 Sep 2026 - Financial Services and Markets Bill [HL] - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and in line with the House
One of 3 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 247 Noes - 165
7 Sep 2026 - Financial Services and Markets Bill [HL] - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and against the House
One of 1 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 59 Noes - 144
7 Sep 2026 - Financial Services and Markets Bill [HL] - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and against the House
One of 2 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 69 Noes - 171
8 Sep 2026 - Plant Health, Seeds, Seed Potatoes and Plant Propagating Material (Amendment) (Northern Ireland) Regulations 2026 - View Vote Context
Lord Weir of Ballyholme voted Aye - in line with the party majority and against the House
One of 5 Democratic Unionist Party Aye votes vs 0 Democratic Unionist Party No votes
Tally: Ayes - 26 Noes - 63


Speeches
Lord Weir of Ballyholme speeches from: Patient Data: Research
Lord Weir of Ballyholme contributed 1 speech (490 words)
Thursday 10th September 2026 - Lords Chamber
Department of Health and Social Care
Lord Weir of Ballyholme speeches from: Plant Health, Seeds, Seed Potatoes and Plant Propagating Material (Amendment) (Northern Ireland) Regulations 2026
Lord Weir of Ballyholme contributed 1 speech (486 words)
Tuesday 8th September 2026 - Lords Chamber
Department for Environment, Food and Rural Affairs
Lord Weir of Ballyholme speeches from: Financial Services and Markets Bill [HL]
Lord Weir of Ballyholme contributed 1 speech (742 words)
Report stage part two
Monday 7th September 2026 - Lords Chamber
HM Treasury


Written Answers
Skin: Surgery
Asked by: Lord Weir of Ballyholme (Democratic Unionist Party - Life peer)
Wednesday 9th September 2026

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to issue national guidance to NHS organisations on the procurement and use of licensed and unlicensed products for perioperative skin preparation.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Skin antisepsis products approved for use in the United Kingdom by the National Health Service are outlined in the British National Formulary. Guidance on skin antisepsis and surgical site infections is outlined by the National Institute for Health and Care Excellence. Further joint guidance from the Royal College of Surgeons and Medicines and Healthcare products Regulatory Agency covers the importance of using medicinally licensed products for perioperative skin preparation.

Adverse events associated with the use of specific medicines and devices in the UK are monitored and recorded via the yellow card scheme. This scheme would apply in the event of adverse events associated with use of an unlicensed product.

Skin: Surgery
Asked by: Lord Weir of Ballyholme (Democratic Unionist Party - Life peer)
Wednesday 9th September 2026

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to monitor patient outcomes and adverse events associated with unlicensed perioperative skin preparation products including their potential impact on surgical site infections and wider NHS costs.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Skin antisepsis products approved for use in the United Kingdom by the National Health Service are outlined in the British National Formulary. Guidance on skin antisepsis and surgical site infections is outlined by the National Institute for Health and Care Excellence. Further joint guidance from the Royal College of Surgeons and Medicines and Healthcare products Regulatory Agency covers the importance of using medicinally licensed products for perioperative skin preparation.

Adverse events associated with the use of specific medicines and devices in the UK are monitored and recorded via the yellow card scheme. This scheme would apply in the event of adverse events associated with use of an unlicensed product.




Lord Weir of Ballyholme mentioned

Parliamentary Debates
Financial Services and Markets Bill [HL]
51 speeches (12,392 words)
Report stage part two
Monday 7th September 2026 - Lords Chamber
HM Treasury
Mentions:
1: Lord Hunt of Wirral (Con - Life peer) I support the noble Baroness, Lady Hoey, and the noble Lords, Lord Weir of Ballyholme and Lord Empey. - Link to Speech